651
A 62-year-old woman who was being treated for squamous cell carcinoma of the head and neck developed a chemotherapy-related hemolytic-uremic syndrome during the second cycle of neoadjuvant chemotherapy consisting of cisplatin, bleomycin, and methotrexate.
 ( adverse event: developed ,  A 62-year-old woman who was being treated for squamous cell carcinoma of the head and neck: Subject, 62-year-old: Subject.Age, woman: Subject.Gender, a chemotherapy-related hemolytic-uremic syndrome: Effect, the second cycle of neoadjuvant chemotherapy consisting of cisplatin, bleomycin, and methotrexate: Treatment, squamous cell carcinoma of the head and neck: Treatment.Disorder, second cycle: Treatment.Dosage, cisplatin: Treatment.Drug, bleomycin: Treatment.Drug, methotrexate: Treatment.Drug, cisplatin: Combination.Drug, bleomycin: Combination.Drug, methotrexate: Combination.Drug) 
Locate the role in the text that participated in the event based on the event type and return it in the event list. 
 Option: Event type: adverse event,potential therapeutic event, Arguments type: Treatment.Disorder,Treatment.Time_elapsed,Treatment.Dosage,Subject.Race,Treatment.Drug,Treatment.Route,Subject.Disorder,Treatment.Freq,Treatment,Effect,Subject.Population,Treatment.Duration,Combination.Drug,Subject,Subject.Age,Subject.Gender. 
Text: {0} 
Answer:
 ( adverse event: developed ,  A 62-year-old woman who was being treated for squamous cell carcinoma of the head and neck: Subject, 62-year-old: Subject.Age, woman: Subject.Gender, a chemotherapy-related hemolytic-uremic syndrome: Effect, the second cycle of neoadjuvant chemotherapy consisting of cisplatin, bleomycin, and methotrexate: Treatment, squamous cell carcinoma of the head and neck: Treatment.Disorder, second cycle: Treatment.Dosage, cisplatin: Treatment.Drug, bleomycin: Treatment.Drug, methotrexate: Treatment.Drug, cisplatin: Combination.Drug, bleomycin: Combination.Drug, methotrexate: Combination.Drug) 